Robert Ham MEng U.S. FDA
Robert Ham MEng U.S. FDA Investigator, OMPTO, ORA
After completing his enlistment in the US Marine Corps, Robert Ham earned a bachelor’s degree in biology. He began his career as a KAN-DO CSO in 2013, where he primarily conducted pharmaceutical inspections. In 2019, he advanced to the role of Drug Specialist for OPQO DIV III, overseeing various pharmaceutical inspections and training junior CSOs. By 2024, he was promoted to Senior CSO for OPQO DIV III. Robert has conducted approximately 100 pharmaceutical inspections worldwide, including aseptic fill, terminally sterilized drug products, APIs, pharmacy compounding, PET, combination products, and more.